SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas
Pathologica · 2023
DOI: 10.32074/1591-951x-847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathologica, 2023. Verfasst von Martina Panozzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Neoplasms, Glandular and Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Among non-small cell lung cancers (NSCLCs), sarcomatoid carcinomas account for 3%. They are rare tumours with a poor prognosis, classified into three subgroups, namely pleomorphic carcinoma, pulmonary blastoma and carcinosarcoma. In the 5th edition of WHO Classification of Thoracic Tumours more space is given to SMARC4-deficient lung cancers. Although studies on SMARCA4-deficient lung tumours are limited, a small percentage of SMARCA4 loss is present within NSCLCs. This finding is clinically relevant, as the loss of the SMARCA4 gene is associated with a worse prognosis. In our study, we analysed the presence of the main catalytic subunit of the SMARCA4 gene, the BRG1 protein, in 60 sarcomatoid lung tumours. The results of our study show that 5.3% of sarcomatoid carcinomas have BRG1-loss in tumour cells, proving that a non-negligible amount of lung sarcomatoid carcinomas are SMARCA4-deficient. These data open the debate on the necessity of including the detection of SMARCA4 within a standardised immunohistochemical panel.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
- Unit of Pathological Anatomy, University Hospital of Pisa, Pisa, Italy.
- Multispecialty Centre for Surgery, Minimally Invasive and Robotic Thoracic Surgery, University Hospital of Pisa, Pisa, Italy.
- Unit of Thoracic Surgery, University Hospital of Pisa, Italy.
Zitieren
APA
Panozzi, M., Alì, G., Proietti, A., Melfi, F., Zirafa, C. C., Lucchi, M., & Fontanini, G. (2023). SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas. Pathologica. https://doi.org/10.32074/1591-951x-847
Vancouver
Panozzi M, Alì G, Proietti A, Melfi F, Zirafa CC, Lucchi M, et al. SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas. Pathologica. 2023. doi:10.32074/1591-951x-847
BibTeX
@article{Panozzi2023,
author = {Panozzi, Martina and Alì, Greta and Proietti, Agnese and Melfi, Franca and Zirafa, Carmelina C and Lucchi, Marco and Fontanini, Gabriella},
title = {SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas},
journal = {Pathologica},
year = {2023},
doi = {10.32074/1591-951x-847}
}
EUVIMED